Answers are grounded in this paper and cite their sources.
Cohort study reveals high diagnostic yield of prenatal exome sequencing in fetuses with structural anomalies, highlighting the value of updating phenotypes and variant classifications postnatally.
Prenatal ES using the NHS England R21 pathway showed great promise when applied to this cohort, allowing a genetic diagnosis to be made in over half of preselected cases with a fetal structural anomaly on ultrasound. Monitoring and real-time updating of fetal phenotype and reclassification of variants based on postnatal findings is vital to increase the clinical impact that is already evident from this emerging genomic technology.
No takes yet. Share an insight, caveat, or question.
Mone et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: